X-68053635-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_002547.3(OPHN1):c.2324+10G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000476 in 1,208,632 control chromosomes in the GnomAD database, including 1 homozygotes. There are 159 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0024 ( 1 hom., 77 hem., cov: 22)
Exomes 𝑓: 0.00028 ( 0 hom. 82 hem. )
Consequence
OPHN1
NM_002547.3 intron
NM_002547.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.515
Genes affected
OPHN1 (HGNC:8148): (oligophrenin 1) This gene encodes a Rho-GTPase-activating protein that promotes GTP hydrolysis of Rho subfamily members. Rho proteins are important mediators of intracellular signal transduction, which affects cell migration and cell morphogenesis. Mutations in this gene are responsible for OPHN1-related X-linked cognitive disability with cerebellar hypoplasia and distinctive facial dysmorhphism. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant X-68053635-C-A is Benign according to our data. Variant chrX-68053635-C-A is described in ClinVar as [Benign]. Clinvar id is 195675.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 77 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OPHN1 | NM_002547.3 | c.2324+10G>T | intron_variant | ENST00000355520.6 | NP_002538.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OPHN1 | ENST00000355520.6 | c.2324+10G>T | intron_variant | 1 | NM_002547.3 | ENSP00000347710.5 |
Frequencies
GnomAD3 genomes AF: 0.00238 AC: 266AN: 111752Hom.: 1 Cov.: 22 AF XY: 0.00227 AC XY: 77AN XY: 33942
GnomAD3 genomes
AF:
AC:
266
AN:
111752
Hom.:
Cov.:
22
AF XY:
AC XY:
77
AN XY:
33942
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000731 AC: 132AN: 180657Hom.: 0 AF XY: 0.000566 AC XY: 37AN XY: 65331
GnomAD3 exomes
AF:
AC:
132
AN:
180657
Hom.:
AF XY:
AC XY:
37
AN XY:
65331
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000281 AC: 308AN: 1096828Hom.: 0 Cov.: 30 AF XY: 0.000226 AC XY: 82AN XY: 362266
GnomAD4 exome
AF:
AC:
308
AN:
1096828
Hom.:
Cov.:
30
AF XY:
AC XY:
82
AN XY:
362266
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00239 AC: 267AN: 111804Hom.: 1 Cov.: 22 AF XY: 0.00226 AC XY: 77AN XY: 34004
GnomAD4 genome
AF:
AC:
267
AN:
111804
Hom.:
Cov.:
22
AF XY:
AC XY:
77
AN XY:
34004
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 25, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 21, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at